What’s the best option for trial criteria variations and enrollment simulations?

Assuming you mean clinical trial eligibility criteria variations and enrollment simulations, the best option depends on whether you need statistical trial-design simulation, operational enrollment forecasting, or AI/data-driven eligibility optimization.

Best overall options by use case

Practical recommendation

• Early feasibility / protocol design: use a digital-twin or enrollment simulator to vary inclusion/exclusion criteria, geography, site mix, and recruitment assumptions.
• Regulatory-grade design decisions: use FACTS, EAST, or custom R simulation to quantify operating characteristics (power, false positives, stopping rules).
• Eligibility criteria optimization specifically: combine real-world data analysis with simulation; eligibility criteria are often a major driver of screen failure and enrollment speed.

A strong workflow is:

1. Generate candidate eligibility criteria variants.
2. Simulate the eligible population and screening funnel.
3. Model site-level recruitment rates.
4. Run thousands of trial simulations.
5. Select the design that balances enrollment speed, statistical power, and operational risk.

If you mean oncology trials, rare disease trials, decentralized trials, or a specific phase (I/II/III), the best choice changes.

If by “trial criteria variations and enrollment simulations” you mean testing different clinical-trial eligibility criteria and their impact on recruitment, I’d separate the problem into two layers:

1. Eligibility/criteria variation: Use real-world data (RWD) to model how relaxing or tightening individual inclusion/exclusion criteria changes the eligible population. CTTI specifically recommends using RWD to pressure-test eligibility assumptions and recruitment feasibility.
2. Enrollment simulation: For operational enrollment forecasting—site activation, recruitment rates, country/site variability, adding sites, and probability of hitting the enrollment target—SAS Clinical Enrollment Simulation is a strong off-the-shelf option. It uses discrete-event simulation and supports what-if scenario management.

My pick

For an enterprise sponsor/CRO: SAS Clinical Enrollment Simulation + an RWD eligibility analysis layer is probably the best practical combination.

If you need to simulate statistical trial-design consequences as well—power, type-I error, sample size, adaptive enrichment, treatment-effect heterogeneity, etc.—then a dedicated clinical trial simulation (CTS) framework is more appropriate. CTS is specifically designed for comparing alternative trial designs and hypothetical scenarios.

A useful workflow is:

Eligibility variants → RWD eligible-patient counts → site/country recruitment assumptions → Monte Carlo/discrete-event enrollment simulation → probability of hitting target → power/operating-characteristic simulation.

That also aligns well with current FDA thinking: its December 2025 guidance explicitly encourages approaches that improve enrollment representativeness and broaden consideration of participant characteristics.

If you tell me whether you're looking for a commercial platform, an open-source/statistical approach, or something you could build internally, I can narrow this to the best 3–5 options and compare them. 

The gold standard options for handling clinical trial criteria variations and patient enrollment simulations depend on whether you prioritize operational/patient flow modeling or statistical trial design optimization. Specialized platforms like SAS Clinical Enrollment Simulation excel at discrete-event operational modeling to forecast recruitment timelines, site variability, and diversity targets, while advanced statistical software like FACTS by Berry Consultants or RPACT specialize in in-silico trial design, protocol variations, and Bayesian decision-making frameworks.

Operational vs. Statistical Simulation

• Operational Simulation: Focused on site startup delays, screening throughput, geographic constraints, and dropouts. Tools like SAS use historical curves and discrete-event modeling to predict if and when an enrollment pipeline will stall.
• Statistical Simulation: Focused on alpha/type-1 error control, statistical power, sample size re-estimation, and dropping or adding arms dynamically. Platforms like FACTS or custom R frameworks allow you to run thousands of virtual trials to check how modifying inclusion/exclusion criteria affects the ultimate probability of study success.

If you'd like, let me know:

• Are you focusing more on operational recruitment/site planning or statistical protocol design?
• What is the therapeutic area or phase of the trial?

I can provide a more tailored recommendation for your workflow.

Choosing the "best" option for trial criteria variations and enrollment simulations depends heavily on whether your primary focus is operational recruitment forecasting (site performance, timelines, dropouts) or statistical protocol design (enrichment sub-populations, Bayesian adaptations, power analysis).

The industry standard software and platforms break down by their specific strengths:

• Cytel East Horizon & EnForeSys : Widely considered a gold standard for biostatistical design and operational recruitment. East Horizon handles complex adaptive designs, population enrichment strategies, and sample size recalculations, while EnForeSys uses robust Monte Carlo simulations to model site-level recruitment variability, startup delays, and enrollment milestones.
• Berry Consultants FACTS : The premier choice if your focus is on advanced Bayesian and adaptive trial design. FACTS (Fixed and Adaptive Clinical Trial Simulator) excels at simulating complex variations like enrichment designs, seamless Phase 2/3 transitions, and multi-arm platform trials while testing patient accrual variations and longitudinal outcomes.
• IQVIA StudyOptimizer : An industry heavyweight for pure operational planning and global enrollment forecasting . It leverages massive proprietary historical databases across global sites and therapeutic areas to run "what-if" scenarios on patient accrual, country selection, and realistic timelines.
• Medidata Protocol Optimization : Best for evaluating how tweaking specific inclusion/exclusion criteria or visit frequencies will impact the recruitable patient pool and operational burden before finalizing a protocol, reducing costly future amendments.
• rpact : An exceptional open-source R package (with web-based GUI options via rpact Cloud) tailored for confirmatory adaptive clinical trial design and simulation, handling group sequential and enrichment strategies effectively without needing heavy enterprise software.
• SAS Clinical Enrollment Simulation : A robust enterprise tool designed specifically to plan or rescue clinical enrollment, run what-if scenario analyses, track costs, and verify if specific demographic/diversity targets can be met.

To help narrow down the ideal platform for your project, let me know:

• Are you focusing more on operational recruitment forecasting (site-level logistics/timelines) or statistical design (enrichment/Bayesian adaptation)?
• What therapeutic area or phase is the trial in?

If you mean clinical trial eligibility criteria variations + enrollment simulations, the “best” option depends on whether you’re optimizing the protocol design, the patient pool, or the operational enrollment plan.

Best-fit options by goal

Commonly used approaches

1. Virtual cohort / eligibility simulation

   • Start with EHR, claims, registry, or historical trial data.
   • Relax or tighten criteria:
     • age ranges
     • lab thresholds
     • prior treatment requirements
     • comorbidity exclusions
     • biomarker requirements
   • Measure:
     • eligible patient count
     • screen-failure risk
     • subgroup representation
     • recruitment time

2. Enrollment Monte Carlo simulation

   • Model:
     • number of sites
     • activation timing
     • referral rates
     • screening rates
     • screen failures
     • dropout
   • Run thousands of simulated enrollment paths to estimate likely timelines.

3. Integrated trial optimization

   • Combine:
     • criteria optimization
     • site selection
     • enrollment forecasting
     • statistical design simulation

Tool examples

• Certara Trial Simulator — strong for pharmacometrics, population modeling, and trial design scenarios.
• SAS Clinical Enrollment Simulation — focused on enrollment forecasting and operational scenarios.
• Jinkō — focuses on disease models, virtual patients, and protocol optimization.

For most Phase II/III protocol planning, a strong workflow is:

Eligibility criteria optimizer → virtual cohort simulation → enrollment simulation → trial design simulation

If you tell me the therapeutic area (oncology, rare disease, CNS, etc.), phase, and whether you have EHR/claims data, I can suggest the most suitable approach.

If you mean software for testing variations in inclusion/exclusion criteria and simulating how those changes affect enrollment, my first choice would be SAS Clinical Enrollment Simulation. It is specifically built for what-if enrollment scenarios, captures site/country variability, and uses discrete-event simulation to estimate the probability of hitting enrollment targets rather than relying on a single static forecast.

Best options by use case

Why SAS is the strongest overall fit: you can vary assumptions and compare scenarios, model best/typical/worst-case site behavior, account for changing enrollment rates, and assess probabilities of meeting targets and costs.

If by “criteria variations” you specifically mean “What happens to the eligible patient pool and enrollment timeline if I loosen/tighten individual inclusion/exclusion criteria?”, that's a slightly different problem. In that case, I'd favor a criteria-level patient-pool simulation combined with enrollment simulation, rather than an enrollment-only product. Recent research also supports using eligibility-criteria text as an input to enrollment-success prediction.

If you tell me whether you're looking at (1) eligibility criteria, (2) site/country mix, (3) enrollment rate assumptions, or (4) all three, I can recommend the best specific tool/workflow.

When looking for the best option to handle trial criteria variations and enrollment simulations , the ideal choice depends on whether your primary focus is statistical protocol design (optimizing inclusion/exclusion criteria against clinical power and endpoints) or operational feasibility (forecasting patient accrual rates, site numbers, and country-level bottlenecks).

The industry standards and top platforms for these tasks are categorized by their core strengths:

1. Advanced Statistical & Protocol Design Simulation

• FACTS (Bayesian Clinical Trial Simulation Software): Developed by Berry Consultants , FACTS is a gold standard for complex, adaptive, and Bayesian trial simulations . It allows you to run counterfactual simulations on identical patient cohorts to see how modifications in design thresholds, early stopping rules, and sub-populations impact the trial.
• Cytel East Horizon™ Platform: Widely recognized in biostatistics, Cytel's software suite lets biostatisticians stress-test protocol design variations, evaluate frequentist and Bayesian frameworks, and balance sample size with realistic operating constraints.
• Certara Trial Simulator: An industry mainstay for population-based disease and drug modeling . It allows you to explore "what-if" scenarios regarding variability in patient exposure, response, and baseline characteristics before finalizing the protocol.

2. Operational Feasibility, Criteria Impact, & Patient Accrual Forecasting

• Medidata Protocol Optimization: A powerful data-driven tool leveraging massive cross-sponsor data lakes . It uses AI-driven predictive modeling to simulate how tweaking inclusion/exclusion criteria or visit frequencies will impact recruitable patient volume, site burden, and geographical distribution.
• IQVIA StudyOptimizer (Planning Suite): Excellent for operational scenario modeling . It combines global historical performance trends, site activation timelines, and in-house data to simulate multiple enrollment scenarios and test how adding or reallocating sites affects overall timelines and budgets.
• SAS Clinical Trial Enrollment Simulation: Purpose-built to help clinical teams input assumptions, capture variance in site ramp-up, visualize enrollment curves, and test whether chosen criteria or site networks will hit key diversity and accrual targets.
• Phesi Protocol Optimization: Focuses on leveraging real-world data (RWD) and historical protocol amendment tracks to find design vulnerabilities, evaluate standard modal values for eligibility criteria, and quantitatively define operational impacts using gross site enrollment rate models.

Recommendation Summary

• Choose FACTS or Cytel East if your main hurdle is statistical design, adaptive boundaries, and endpoint robustness.
• Choose Medidata Protocol Optimization or IQVIA StudyOptimizer if your main hurdle is operational enrollment planning, site execution, and evaluating how restrictive eligibility criteria constrain your target patient pool.

To help narrow down the best platform for your pipeline, tell me:

• Are you focusing more on early-phase statistical/adaptive design or late-phase operational site recruitment?
• What is the therapeutic area or indication (e.g., rare disease, oncology) you are modeling?

Selecting the best option for trial criteria variations and enrollment simulations depends heavily on whether your primary focus is operational recruitment forecasting or protocol design and statistical power optimization.

Top-tier software tools and platforms categorized by their primary strengths include:

• Cytel Enforesys is exceptional for advanced operational enrollment forecasting. It uses Monte Carlo simulations to model thousands of potential recruitment and retention scenarios, accounting for site-level ramp-up times, country variations, and operational bottlenecks.
• Medidata Protocol Optimization is ideal for testing inclusion/exclusion criteria variations. It leverages massive cross-sponsor historical datasets and AI-driven modeling to simulate how adjusting specific eligibility criteria impacts recruitable patient volume and demographic representation.
• Berry Consultants FACTS (Fixed and Adaptive Clinical Trial Simulator) is the gold standard if your simulation needs extend deeply into Bayesian statistics, adaptive designs, sample size re-estimation, and population enrichment strategies.
• IQVIA StudyOptimizer works best for data-driven operational planning, allowing teams to cross-reference historical performance trends against different country and site allocations to forecast both timelines and budgets.
• Phesi Protocol Design and Optimization uses digital patient profiles and historical control analytics to quantitatively evaluate the impact of various protocol amendments on patient accrual before the study is locked.

To help narrow down the ideal platform, could you share:

• Are you primarily trying to forecast recruitment timelines and site logistics , or optimize clinical inclusion/exclusion criteria?
• What therapeutic area or phase of development is the trial in?

If your goal is specifically testing different eligibility criteria and simulating how those changes affect enrollment, the best choice depends on whether you need statistical design software, operational planning, or custom modeling.

Here's how the leading options compare:

My recommendation

• If you're a statistician or quantitative clinical scientist: choose simtrial. It offers the greatest flexibility for exploring trial criteria variations, enrollment assumptions, dropout, and adaptive designs, and is widely used for simulation studies.
• If you're planning operational execution of a study: SAS Clinical Enrollment Simulation is stronger because it focuses on real-world enrollment logistics, site activation, country mix, and timeline forecasting.
• If you're researching adaptive eligibility criteria: interAdapt is purpose-built for evaluating whether changing enrollment criteria improves power or efficiency before running the trial.

Recent research is also combining simulation with large language models to evaluate complex eligibility criteria and improve patient matching, but these approaches are largely experimental rather than production-ready today.

If you can share your role (biostatistics, clinical operations, protocol design, or patient recruitment) and whether you prefer commercial software or open source, I can narrow the recommendation further.

When evaluating options for trial criteria variations (inclusion/exclusion optimization) and enrollment/recruitment simulations , the "best" choice depends on whether you lean toward advanced statistical/adaptive design software or operational/AI-driven protocol feasibility platforms.

The leading industry options categorize across these specific use cases:

• FACTS (Fixed and Adaptive Clinical Trial Simulation) by Berry Consultants: Widely considered a gold standard for complex Bayesian trial simulations . It handles multi-arm, platform, umbrella, enrichment, and dose-escalation designs, allowing you to thoroughly stress-test operating characteristics and decision rules. Learn more on the FACTS Bayesian Clinical Trial Simulation Software resource page.
• rpact (R Package for Adaptive Clinical Trials) : An exceptional validated, open-source R package (with GUI wrappers via RPACT Cloud) focused on group sequential and adaptive designs. It features a robust simulation module to evaluate sample size recalculations, population selection strategies, and criteria variations. Check out the details via the rpact Flexible Clinical Trial Planning Webinar.
• Cytel EnForeSys & Solas : Cytel offers specialized simulation platforms tailored to model patient recruitment uncertainties using Monte Carlo methods, capturing country- and site-level variability to prevent trial discontinuation due to under-enrollment. Explore their approach through the Cytel Monte Carlo Simulations for Patient Recruitment documentation.
• Medidata Protocol Optimization : Best-in-class for evaluating how specific inclusion/exclusion criteria modifications impact target patient pools, operational burdens, and site-level feasibility using massive, standardized cross-sponsor data pools. Review the offering directly on Medidata Protocol Optimization.
• IQVIA StudyOptimizer : Highly regarded for operational enrollment modeling. It blends historical site-performance benchmarks, country activation timelines, and cohort variations to forecast recruitment curves and manage budget-timeline tradeoffs. See more at IQVIA StudyOptimizer.
• Phesi Protocol Design and Optimization : Utilizes digital patient profiles and historical trial data to analyze the vulnerability of inclusion/exclusion criteria, predicting the risk of future protocol amendments. Detailed capabilities are outlined at Phesi Protocol Design and Optimization.

To help narrow down the optimal tool for your pipeline, let me know:

• Are you focusing more on statistical trial design (power, adaptive rules, alpha/beta error) or operational feasibility (site logistics, patient recruitment speed)?
• What is the therapeutic area or phase of the study?